“GSK Expands Respiratory Portfolio with Aiolos Bio Acquisition”
GSK's acquisition of Aiolos Bio expands respiratory treatment options, introducing AIO-001, a promising new treatment for asthma patients.
- Latest
- Trending
GSK's acquisition of Aiolos Bio expands respiratory treatment options, introducing AIO-001, a promising new treatment for asthma patients.
KuCoin's user base grew by 16% in 2023, reaching 31 million users worldwide, while spot trading volume surged by 106%, ...
Netflix shares drop 2% as Citi cuts rating due to "lofty expectations" for 2024 and 2025. Concerns over revenue growth, ...
ZIM integrates advanced tracking devices from Hoopo Systems to enhance supply chain management and improve customer service. #shipping #technology
ByteDance is reportedly looking to sell off its gaming assets, signaling a shift away from the gaming industry and a ...
GRC startup Anecdotes raises $25M in Series B funding round to expand its automated workflows and AI Toolkit for compliance ...
UBS Global Wealth Management analyst predicts active investing to outperform passive strategies in 2024 due to higher returns and better ...
The rise of social fitness apps is transforming the way we approach fitness, with apps like Strava and Peloton creating ...
Nexen Tire develops VR system to enhance digital design capabilities, improving product quality and reducing costs in the automotive industry.
Northern Revival Acquisition Corporation (NRAC) and Braiin Limited file registration statement with SEC for a potential business combination valued at ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.